>
Organization
Neurocrine Biosciences Inc.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed

News on Neurocrine Biosciences Inc.

... PR Newswire Neurocrine Biosciences, Inc. (NASDAQ: NBIX) today announced that a new analysis of INGREZZA® (valbenazine) capsules, ...
... PR Newswire Neurocrine Biosciences, Inc. (NASDAQ: NBIX) announced today that it will report fourth quarter and year-end ...
... Biopharmaceutical company Neurocrine Biosciences Inc (NASDAQ:NBIX) stated on Sunday that it expects net product sales of ...
... PR Newswire Neurocrine Biosciences, Inc. (NASDAQ: NBIX) today provided an update on its business performance, including preliminary ...
... PR Newswire Neurocrine Biosciences, Inc. (NASDAQ: NBIX) will present at the 37th Annual J.P. Morgan Healthcare Conference ...
... Last year, Neurocrine's Ingrezza failed a phase 2 trial in pediatric Tourette Syndrome patients, prompting ...
... PR Newswire Neurocrine Biosciences, Inc. (NASDAQ: NBIX) today announced topline data from the Phase IIb T-Force GOLD ...
... PR Newswire Neurocrine Biosciences, Inc. (NASDAQ: NBIX) will present at the Jefferies 2018 London Healthcare Conference at ...
Subscribe now for full coverage on Neurocrine Biosciences Inc.
Start My Free Trial